Philips Electronics announced the receipt of a Medical Device License from the Therapeutic Products Directorate, Medical Devices Bureau of Health Canada for its HeartStart Home Defibrillator. According to the company, the defibrillator provides treatment for sudden cardiac arrest, a leading cause of death in Canada claiming approximately 35,000 to 40,000 lives each year. The result of extensive research on ease of use, the product is intended to help the emerging class of home responders use a defibrillator to help save a life, the company said. Philips also received license from Health Canada for its HeartStart OnSite Defibrillator for minimally trained lay responders who are typically found in businesses, schools, and communities.
According to the company, built-in SMART Pad technology senses a responder's actions and automatically adjusts the pace of voice instructions to match the individual responder's needs. Clear, calm voice commands guide the responder through every step of the defibrillation process, even reminding them to call for emergency help. Patented voice coaching for adult and infant/child CPR provides instructions and audio cues for each breath as well as the appropriate number, rate, and depth of chest compressions, said the company. In addition, the HeartStart Home Defibrillator and the HeartStart OnSite Defibrillator can reportedly be used on infants and children under 8 years of age or weighing less than 25 kg when equipped with specially designed infant/child pads, which reduce the amount of energy delivered by the defibrillator to an appropriate level.
to Daily News